Peregrine Pharmaceuticals Prices Offering of Its Series E Preferred Stock

[Marketwired] – Peregrine Pharmaceuticals, Inc. , announced today that it has priced an underwritten public offering of 700,000 shares of its 10.50% Series E Convertible Preferred Stock at a public offering price of $25.00 … more

View todays social media effects on PPHM

View the latest stocks trending across Twitter. Click to view dashboard

See who Peregrine is hiring next, click here to view